Experience
Acura Pharmaceuticals Incorporated
Sandoz, Inc.
Represented Acura in an ANDA litigation against several generic manufacturers concerning Acura's Oxecta® abuse deterrent oxycodone product. Successfully negotiated settlement prior to trial.
Acura Pharmaceuticals Incorporated v. Sandoz, Inc., 1:12-cv-01373, D. Del., Judge Andrews
Apotex Inc. v. Senju Pharmaceutical
Senju Pharmaceuticals Co. Ltd.
Abbott Laboratories v. Sandoz Inc.
Abbott Laboratories
Shionogi Pharmaceuticals v. Apotex/Sandoz
Shionogi Pharmaceuticals
NeXstar Pharmaceuticals v. Liposome Co.
NeXstar Pharmaceuticals
Housey Pharmaceuticals, Inc. v. Otsuka Pharmaceutical Co. Ltd.
Otsuka Pharmaceutical Co. Ltd.
AstraZeneca Pharmaceuticals LP, Shionogi Co. v. Watson Pharmaceuticals, Inc.
AstraZeneca Pharmaceuticals LP; Shionogi Co.
Pronova Biopharma Norge AS v. Teva Pharmaceuticals USA, Inc.
Pronova Biopharma Norge AS
Neste Oil Oyj v. Dynamic Fuels, LLC
Neste Oil
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.